184 related articles for article (PubMed ID: 32211837)
1. A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders.
Lenze EJ; Rodebaugh TL; Nicol GE
JAMA Psychiatry; 2020 Jul; 77(7):663-664. PubMed ID: 32211837
[No Abstract] [Full Text] [Related]
2. Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders.
Lenze EJ; Nicol GE; Barbour DL; Kannampallil T; Wong AWK; Piccirillo J; Drysdale AT; Sylvester CM; Haddad R; Miller JP; Low CA; Lenze SN; Freedland KE; Rodebaugh TL
J Psychiatry Neurosci; 2021 Jan; 46(1):E97-E110. PubMed ID: 33206039
[TBL] [Abstract][Full Text] [Related]
3. Statistical pitfalls of personalized medicine.
Senn S
Nature; 2018 Nov; 563(7733):619-621. PubMed ID: 30482931
[No Abstract] [Full Text] [Related]
4. A response to Wasan editorial "Spinal cord stimulation in a workers' compensation population: how difficult it can be to interpret a clinical trial": stimulating discussion.
Turner JA; Hollingworth W; Comstock BA; Deyo RA
Pain; 2010 May; 149(2):406-407. PubMed ID: 20207083
[No Abstract] [Full Text] [Related]
5. Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.
Moore RA; Derry S; McQuay HJ; Straube S; Aldington D; Wiffen P; Bell RF; Kalso E; Rowbotham MC;
Pain; 2010 May; 149(2):173-176. PubMed ID: 19748185
[No Abstract] [Full Text] [Related]
6. Community-driven development of a modified progression-free survival ratio for precision oncology.
Mock A; Heilig CE; Kreutzfeldt S; Huebschmann D; Heining C; Schröck E; Brors B; Stenzinger A; Jäger D; Schlenk R; Glimm H; Fröhling S; Horak P;
ESMO Open; 2019; 4(6):e000583. PubMed ID: 31798980
[TBL] [Abstract][Full Text] [Related]
7. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.
Turk DC; Dworkin RH; Burke LB; Gershon R; Rothman M; Scott J; Allen RR; Atkinson HJ; Chandler J; Cleeland C; Cowan P; Dimitrova R; Dionne R; Farrar JT; Haythornthwaite JA; Hertz S; Jadad AR; Jensen MP; Kellstein D; Kerns RD; Manning DC; Martin S; Max MB; McDermott MP; McGrath P; Moulin DE; Nurmikko T; Quessy S; Raja S; Rappaport BA; Rauschkolb C; Robinson JP; Royal MA; Simon L; Stauffer JW; Stucki G; Tollett J; von Stein T; Wallace MS; Wernicke J; White RE; Williams AC; Witter J; Wyrwich KW
Pain; 2006 Dec; 125(3):208-215. PubMed ID: 17069973
[No Abstract] [Full Text] [Related]
8. What works for whom, when and how?
Seers K
Pain; 2009 Jun; 143(3):167-168. PubMed ID: 19339114
[No Abstract] [Full Text] [Related]
9. Reply to Drs. Olanow and Rascol.
Ahlskog JE; Uitti RJ
Neurology; 2010 Apr; 74(14):1151. PubMed ID: 20368636
[No Abstract] [Full Text] [Related]
10. Cut-points for the measurement of pain: the choice depends on what you want to study.
Farrar JT
Pain; 2010 May; 149(2):163-164. PubMed ID: 20347224
[No Abstract] [Full Text] [Related]
11. Chronic low back pain analgesic studies--a methodological minefield.
Moore AR; Straube S; Derry S; McQuay HJ
Pain; 2010 Jun; 149(3):431-434. PubMed ID: 20304558
[No Abstract] [Full Text] [Related]
12. Clinical trials are only as good as the patient- important outcome measures assessed.
J Clin Epidemiol; 2020 Sep; 125():A7-A9. PubMed ID: 32862954
[No Abstract] [Full Text] [Related]
13. Time to change the primary outcome of lupus trials.
Houssiau FA
Ann Rheum Dis; 2019 May; 78(5):581-582. PubMed ID: 29921574
[No Abstract] [Full Text] [Related]
14. Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder.
Strain EC; Kampman KM; Weiss RD
JAMA Psychiatry; 2021 Jul; 78(7):701-702. PubMed ID: 33851964
[No Abstract] [Full Text] [Related]
15. Optimal Individualized Treatments in Resource-Limited Settings.
Luedtke AR; van der Laan MJ
Int J Biostat; 2016 May; 12(1):283-303. PubMed ID: 27227725
[TBL] [Abstract][Full Text] [Related]
16. Clinical research in critical care. Difficulties and perspectives.
Latour-Pérez J
Med Intensiva (Engl Ed); 2018 Apr; 42(3):184-195. PubMed ID: 28943024
[TBL] [Abstract][Full Text] [Related]
17. Hitting the target: a new framework for mental health trials.
Lancet; 2014 Mar; 383(9921):928. PubMed ID: 24629280
[No Abstract] [Full Text] [Related]
18. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations.
Hobart JC; Cano SJ; Zajicek JP; Thompson AJ
Lancet Neurol; 2007 Dec; 6(12):1094-105. PubMed ID: 18031706
[TBL] [Abstract][Full Text] [Related]
19. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
20. Rethinking Clinical Trials and Personalized Medicine with Placebogenomics and Placebo Dose.
Özdemir V; Endrenyi L
OMICS; 2021 Jan; 25(1):1-12. PubMed ID: 33305994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
